Table 1.
Basic characteristics of STRRIDE-PD participants.
| Variable | STRRIDE-PD Group (N=106 total) | ||||
|---|---|---|---|---|---|
| Low-Mod N=29 |
High-Mod N=27 |
High-Vig N=24 |
Clinical Lifestyle N=26 |
||
| Male/Female (N) | 11/18 | 11/16 | 8/16 | 9/17 | |
| White (%) | 79 | 81 | 71 | 77 | |
| Age (yrs) | 56.8 ± 8.1 | 61.0 ± 6.5 | 58.6 ± 6.7 | 57.0 ± 7.9 | |
| Cholesterol medication use, N (%) | Baseline | 6 (21%) | 3 (11%) | 6 (25%) | 7 (27%) |
| Post-training | 6 (21%) | 3 (11%) | 5 (21%) | 4 (15%) | |
| Weight (kg) | Baseline | 87.4 ± 11.5 | 86.6 ± 11.9 | 84.9 ± 9.9 | 88.4 ± 16.0 |
| Delta* | −0.5 ± 3.0 | −1.5 ± 2.8‡ | −1.5 ± 3.2‡ | −6.5 ± 5.5§ | |
| BMI (kg/m2) | Baseline | 31.3 ± 1.1 | 31.6 ± 5.1 | 30.4 ± 4.4 | 31.6 ± 6.8 |
| Delta* | −0.2 ± 1.0 | −0.6 ± 1.1‡ | −0.6 ± 1.1‡ | −2.3 ± 1.9§ | |
| HDL-C (mg/dl) | Baseline | 48 ± 24 | 46 ± 13 | 45 ± 12 | 43 ± 12 |
| Delta | −2 ± 14 | 0 ± 5 | 3 ± 5‡ | 2 ± 7 | |
| TG (mg/dl) | Baseline | 125 ± 57 | 116 ± 36 | 136 ± 77 | 119 ± 58 |
| Delta† | 1 ± 46 | 14 ± 45 | −14 ± 46 | −23 ± 36‡ | |
| Total Cholesterol (mg/dl) | Baseline | 188 ± 40 | 190 ± 27 | 184 ± 25 | 177 ± 33 |
| Delta | 1 ± 23 | 0 ± 18 | −2 ± 16 | −6 ± 22 | |
| 3H efflux (global) | Baseline | 0.7 ±0.2 | 0.8 ± 0.3 | 0.9 ± 0.2 | 0.9 ± 0.2 |
| Delta | −0.03 ± 0.1 | −0.04 ± 0.2 | 0.05 ± 0.2 | −0.04 ± 0.1 | |
| BODIPY efflux | Baseline | 0.6 ±0.2 | 0.71± 0.2 | 0.7 ± 0.2 | 0.7 ± 0.2 |
| Delta | 0.04 ± 0.2 | −0.02 ± 0.1 | −0.02 ± 0.2 | −0.06 ± 0.2 | |
| HAE | Baseline | 49.8 ± 11.8 | 47.2 ± 9.7 | 48.8 ± 10.2 | 49.4 ± 7.5 |
| Delta | −1.5 ± 7.9 | 1.3 ± 5.5 | 1.6 ± 4.6 | 0.2 ± 6.5 | |
Data represented as mean ± SD. Delta = post-training value – baseline value.
p<0.0001 and
p=0.04 for differences in mean values between groups.
Clinical lifestyle mean value significantly different from all other groups.
High-Mod group different from Low-Mod and Clinical Lifestyle groups.
p<0.05 and
p<0.0001 for within group training response (paired t-test of difference from baseline).
BMI, body mass index; TG, triglycerides.